Presentation + Paper
12 March 2024 In vitro and in vivo evaluations of focused ultrasound induced immunomodulation in osteosarcoma
Author Affiliations +
Proceedings Volume 12843, Biophotonics and Immune Responses XIX; 1284303 (2024) https://doi.org/10.1117/12.3005917
Event: SPIE BiOS, 2024, San Francisco, California, United States
Abstract
Osteosarcoma (OS) is the most common primary bone tumor in dogs and humans and is considered an immunologically “cold” tumor. OS exerts devastating impacts on patients and has not seen significant improvements in survival outcomes in decades, with resistant metastatic disease remaining a main cause of death. Innovative therapies are profoundly needed to improve treatment and outcomes in OS. Canine OS shares striking similarities with human OS but occurs at a greater prevalence, allowing the dog to serve as a valuable comparative oncology research model. Histotripsy, a novel non-thermal focused ultrasound technique, has potential to ablate the primary tumor and activate an immune response to mitigate metastatic disease, thus promising to turn OS into an immunologically “hot” tumor. The objective of this study was to evaluate the immunomodulatory effects of histotripsy after in vitro and in vivo OS ablation. We utilized in vitro cell culture models for mechanistic cell death and immune response evaluation. We delivered histotripsy in vivo to canine OS patients and assessed peripheral immune cells and the tumor microenvironment. Across species, after in vitro exposure of immune cells to histotripsy-ablated OS cells, we observed cellular phenotypic changes indicative of activation and upregulation of genes associated with immune cell chemotaxis, immune and inflammatory responses such as NK cell-mediated cytotoxicity. In vivo, histotripsy ablation led to significantly greater expression of activation markers CD80 and CD62L on circulating monocytes at 1 and 5 days post histotripsy (DPH) respectively. We observed significantly higher production of TGFβ in circulating monocytes at 3 DPH compared to baseline. On an independent patient basis, we observed a greater population of infiltrating CD5+CD4+ and CD5+CD8+ T-lymphocytes within the ablated compared to unablated regions of tumor, and noted intratumoral genetic signatures that indicate immune activation at 24 hours post histotripsy. Collectively our results suggest that histotripsy ablation of OS leads to immune activation.
Conference Presentation
© (2024) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Alayna Hay, Lauren Ruger, Elliana Vickers, Manali Patwardhan, Sheryl Coutermarsh-Ott, Eli Vlaisavljevich, and Joanne Tuohy "In vitro and in vivo evaluations of focused ultrasound induced immunomodulation in osteosarcoma", Proc. SPIE 12843, Biophotonics and Immune Responses XIX, 1284303 (12 March 2024); https://doi.org/10.1117/12.3005917
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Ablation

Tumors

In vitro testing

Diseases and disorders

Ultrasonography

Cell death

Bone

Back to Top